Scinai Immunotherapeutics Ltd (SCNI) — Cash Flow Quality Index
Scinai Immunotherapeutics Ltd (SCNI) has a Cash Flow Quality Index of -0.19x as of September 2024. Operating cash flow of $-2.04 Million is below net income of $10.49 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Scinai Immunotherapeutics Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Scinai Immunotherapeutics Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Scinai Immunotherapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SCNI tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Scinai Immunotherapeutics Ltd (2024–2024)
Year-by-year earnings quality comparison for Scinai Immunotherapeutics Ltd. For live market cap and the full company financial profile, see Scinai Immunotherapeutics Ltd market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | $-6.33 Million | $4.80 Million | — |